React4life SpA

React4life SpA is an SME in Genova, Italy that has taken part in 8 EU-funded projects since 2018, receiving €2.7M in EU funding and leading 1 as coordinator.

EU funding received€2.7M
EU projects8
As coordinator1
Running now6
First EU project2018
Latest project2026
CountryItaly
EU registration (PIC)915816383
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are React4life SpA's own share of each project, not the project's full budget.

  • Horizon Europe€2.3M · 6 projects
  • Horizon 2020€457k · 2 projects

Projects

8 EU-funded projects, newest first. React4life SpA led 1 of them as coordinator. Each links to the official record.

  • IMPACTPartner

    Intelligent Manufacturing Platform for Advanced CAR Therapies

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €787ktheir share
  • CMT-DNPartner

    Tiny Machines Working to Elucidate Mechanisms of Cerebrovascular Pathologies

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €282ktheir share
  • Mac4MePartner

    Macrophage Targets for Metastatic Treatment

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €259ktheir share
  • COMBATPartner

    Advancing Pandemic Preparedness: Innovative Multidisciplinary Strategies for COMBATing Severe Dengue

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €428ktheir share
  • PRESSUREPartner

    Preventing Therapy Resistance in Esophageal Cancer Using Advanced Models and Molecular Signatures

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €259ktheir share
  • GlycoNoViPartner

    Understanding the Role of Glycans in Human Norovirus Infection: a Key to Unlock New Therapies

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €259ktheir share
  • MOODCoordinator

    Feasibility Study for the introduction into pre-clinical study domain of the first-of-a-kind Multi Organ On Device (MOOD) technology

    Horizon 2020 · 2018–2019 · Project on CORDIS ↗

    €50ktheir share
  • B2BPartner

    Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity.

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €407ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA viruses
  • bioreactors
  • breast cancer
  • carbohydrates
  • cell signaling
  • cells technologies
  • drug discovery
  • employment
  • immunotherapy
  • machine learning
  • manufacturing engineering
  • molecular biology
  • mortality
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime